Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    Open Studies | "Progeria"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Condition: Progeria
Intervention: Drug: Everolimus and lonafarnib

Indicates status has not been verified in more than two years